9^th International Conference on Neuro-Oncology and Brain Tumor December 19-20, 2022 Rome, Italy

Michael Retsky has PhD in experimental physics from University of Chicago 1974. He made a career change to cancer research in 1980s while working at Hewlett-Packard in Colorado Springs. He became Prof of Biology at University of Colorado and later visiting Prof in Medical Oncology at University of Texas - San Antonio. He was on Judah Folkman’s staff at Harvard Medical School for 12 years during which time the dormancy research got started. Diagnosed with stage IIIc colon cancer in 1994, he was the first person to use metronomic chemotherapy. He is now on staff at Harvard TH Chan School of Public Health. With Romano Demicheli he edited a book: Perioperative Inflammation as Triggering Origin of Metastasis Development (Springer- Nature 2017). He has 3 patents pending on methods to prevent late relapses. His over 100 papers in Physics and Oncology have been cited over 2500 times.

Metastasis cancer

MS. SUCHI is an experienced International Pre School Principal/Manager who picked up Laughter exercises from many coaches around the world. She then designed ‘Laughter Therapy' which is being used in many places such as hospitals and Senior Activity Centres. She provides individual and group therapy in educational and home settings. A former Manager / Trainer is now engages in building social awareness about Holistic approach for recovery. Be it Depression, Anxiety caused by physical or emotional pain, Death in the family and the harm the unhappiness brings to people, families and communities. Her aim is to encourage people to seek help early and get on the path to recovery. Her works has been featured in local press, TV and Radio and has been an invited speaker at various community clubs and educational Institutions. She has also been awarded by MINDS and various community clubs in recognition of her social work.

Neurology/Psychiatry /Public Health

Catherine Maurice completed her residency training in Neurology at the University of Montreal in 2013. She then started a 2-year fellowship in neuro-oncology at the Pencer Brain Tumor Centre of Princess Margaret Hospital, Toronto, under the supervision of Dr Warren P. Mason. In 2015, University of Toronto Health Network recruited Dr. Catherine Maurice to work as an attending physician and clinical teacher. She developed a new neuro-oncology clinic focusing on the to assessment of neurologic complications resulting from systemic cancers and novel therapies. She also manages another clinic focused on primary brain tumors and is enrolled in the multidisciplinary Gamma-Knife Clinic of the Krembil Neuroscience Centre. Dr. Maurice is actively involved in teaching, trying to incorporate new technologies and virtual reality into medical education.

Brain and Cancer

Dr. Yumin Zhang, is an Associate Professor in the Department of Anatomy, Physiology and Genetics and the Department of Neuroscience at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. Dr. Zhang obtained his MD in Binzhou Medical School, China, PhD in Hebrew University of Jerusalem, Israel, and postdoc study in the Children’s Hospital, Harvard Medical School. The major research interest in Dr. Zhang’s lab is to study how modulation of the arachidonic acid metabolism and the endocannabinoid system can impact the pathogenesis and treatment for neurological diseases, including traumatic brain injury and multiple sclerosis.

neurological diseases, including traumatic brain injury and multiple sclerosis

Senior Member, American Society of Neuroradiology.Double Boarded, American Board of Radiology:Radiology (2000, permanent) Neuroradiology (2002, recertified 2012) Certificate of Added Qualifications in Neuroradiology. American Board of Radiology, 2002

Brain MRI: Brain Tumors, Brain Trauma Neurodegenerative Diseases, Congenital Malformations, Brain Infection Head and Neck Cancers.